Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quanta Dialysis Technologies Ltd

https://www.quantadt.com/

Latest From Quanta Dialysis Technologies Ltd

Quanta CEO Speaks On US Expansion, Talent Acquisition, And Addressable Markets

Since closing its $245m funding raise, Quanta Dialysis Technologies has been scaling up its commercial infrastructure and bolstering its US presence.

Innovation Renal

‘Investee’ Eye: Quanta CEO’s Perspective Of Seeking And Obtaining $245m Raise

Quanta CEO John Milad outlines the transitional stage where a company begins to seek large-scale funding for the first time, and debates market valuations.

Investor Eye Financing

Digital Health Roundup, June 2021: Winners In Record-Breaking H1 Digital Health Funding; ADA 2021; Telehealth Update

In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from June.

Digital Health Telehealth

Quanta Raises $245M In Series D, Plans To Expand Into Home-Based Dialysis In US

UK-based Quanta will use the proceeds to ramp up European commercialization and bring its SC+ portable hemodialysis system to US-based acute and chronic care facilities, but ultimately hopes to enter the rising US home-based dialysis market.

Financing Clinical Trials
See All

Company Information

  • Industry
  • Medical Devices
  • Other Names / Subsidiaries
    • Quanta Fluid Solutions Ltd.
UsernamePublicRestriction

Register